When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?-Reference-Cited by-同舟云学术

When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?

Published:2017-09-25 Issue:6 Volume:102 Page:924-933
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Franklin Jessica M.¹,Schneeweiss Sebastian¹

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics; Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts USA

Funder

Brigham and Women's Hospital

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.857/fullpdf

Reference79 articles.

1. Bonamici S H.R.34 - 114th Congress (2015-2016): 21st Century Cures Act https://www.congress.gov/bill/114th-congress/house-bill/34 2016

2. U.S. Food and Drug Administration Prescription Drug User Fee Act (PDUFA) - PDUFA VI: Fiscal Years 2018-2022 https://www.fda.gov/forindustry/userfees/prescriptiondruguserfee/ucm446608.htm 2017

3. A review of uses of health care utilization databases for epidemiologic research on therapeutics;Schneeweiss;J. Clin. Epidemiol.,2005

4. Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development;Schneeweiss;Clin. Pharmacol. Ther.,2011

5. Improving therapeutic effectiveness and safety through big healthcare data;Schneeweiss;Clin. Pharmacol. Ther.,2016

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer registry as external control data for regulatory submission in Japan;ESMO Real World Data and Digital Oncology;2024-12

2. Sociodemographics and clinical factors associated with depression treatment outcomes in 65,741 first-time users of selective serotonin reuptake inhibitors: A Danish cohort study in older adults;Journal of Affective Disorders;2024-12

3. Methodological Challenges using Routine Clinical Care Data for Real-World Evidence: a Rapid Review utilizing a systematic literature search and focus group discussion;2024-09-06

4. Health technology assessments of new specialized therapies: A typology of key challenges and potential policy solutions;Health Policy and Technology;2024-09

5. A Two‐Step Framework for Validating Causal Effect Estimates;Pharmacoepidemiology and Drug Safety;2024-09